Used to monitor minimal residual disease in Philadelphia chromosome positive CML or AML patients being treated with tyrosine kinase inhibitors.
Interpretive report provided
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
4 - 8 days
Collect specimen and transfer to an EDTA lavender top tube. Send intact bone marrow to Specimen Processing room temperature
Test performed by Versiti